CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 1,957 shares at an average $36.08 ($70,608)
- 4 Planned sale Director sold 201 shares at an average $28.63 ($5,755)
- 4 Planned sale Director sold 2,560 shares at an average $31.80 ($81,407)
- 4 Exercise or conversion Chief Medical Officer acquired 21,870 shares (option exercise)
- 4 Open-market sale Director sold 26,157 shares at $73.50 ($1,922,540)
- 4 Grant or award Chief Financial Officer acquired 18,165 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 66,365 shares (grant or award)
- 4 Grant or award General Counsel acquired 14,035 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 18,165 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 18,535 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 36,666 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 36,666 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 102,500 shares at $67.65 ($6,934,125)
Page 7 of 15 · 283 filings